← FDA Drug Approvals (Drugs@FDA)
DOXIL (LIPOSOMAL)
NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 1995-11-17
Drug application
- FDA Application #
NDA050718- Application type
- New Drug Application
- Brand name
- DOXIL (LIPOSOMAL)
- Generic name
- DOXORUBICIN HYDROCHLORIDE LIPOSOME
- Active ingredients
- DOXORUBICIN HYDROCHLORIDE
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- BAXTER HLTHCARE CORP
- Manufacturer
- Baxter Healthcare Company
- First approval
- 1995-11-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown